The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in developing acute pancreatitis after taking GLP-1 weight-loss drugs like Ozempic, Mounjaro, and Wegovy.
from mint - news https://ift.tt/KlVx89Y
UK investigates weight-loss jab risks after many hospitalised with pancreatitis
June 26, 2025
0
Tags
